A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?

Eldafashi, Nardeen; Darlay, Rebecca; Shukla, Ruchi; McCain, Misti Vanette; Watson, Robyn; Liu, Yang Lin; McStraw, Nikki; Fathy, Moustafa; Fawzy, Michael Atef; Zaki, Marco Y W; Daly, Ann K; Maurício, João P; Burt, Alastair D; Haugk, Beate; Cordell, Heather J; Bianco, Cristiana; Dufour, Jean-François; Valenti, Luca; Anstee, Quentin M and Reeves, Helen L (2021). A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? Cancers, 13(6) MDPI AG 10.3390/cancers13061412

[img]
Preview
Text
cancers-13-01412.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Obesity and non-alcoholic fatty liver disease (NAFLD) are contributing to the global rise in deaths from hepatocellular carcinoma (HCC). The pathogenesis of NAFLD-HCC is not well understood. The severity of hepatic steatosis, steatohepatitis and fibrosis are key pathogenic mechanisms, but animal studies suggest altered immune responses are also involved. Genetic studies have so far highlighted a major role of gene variants promoting fat deposition in the liver (PNPLA3 rs738409; TM6SF2 rs58542926). Here, we have considered single-nucleotide polymorphisms (SNPs) in candidate immunoregulatory genes (MICA rs2596542; CD44 rs187115; PDCD1 rs7421861 and rs10204525), in 594 patients with NAFLD and 391 with NAFLD-HCC, from three European centres. Associations between age, body mass index, diabetes, cirrhosis and SNPs with HCC development were explored. PNPLA3 and TM6SF2 SNPs were associated with both progression to cirrhosis and NAFLD-HCC development, while PDCD1 SNPs were specifically associated with NAFLD-HCC risk, regardless of cirrhosis. PDCD1 rs7421861 was independently associated with NAFLD-HCC development, while PDCD1 rs10204525 acquired significance after adjusting for other risks, being most notable in the smaller numbers of women with NAFLD-HCC. The study highlights the potential impact of inter individual variation in immune tolerance induction in patients with NAFLD, both in the presence and absence of cirrhosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

UniBE Contributor:

Dufour, Jean-François

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2072-6694

Publisher:

MDPI AG

Language:

English

Submitter:

Rahel Fuhrer

Date Deposited:

29 Aug 2021 23:12

Last Modified:

05 Dec 2022 15:52

Publisher DOI:

10.3390/cancers13061412

PubMed ID:

33808740

Uncontrolled Keywords:

PD-1 PDCD1 PNPLA3 TM6SF2 genetic predisposition hepatocellular carcinoma metabolic syndrome primary liver cancer single-nucleotide polymorphism

BORIS DOI:

10.48350/158001

URI:

https://boris.unibe.ch/id/eprint/158001

Actions (login required)

Edit item Edit item
Provide Feedback